C1 inhibitor muteins and uses thereof
US5622930A · kind A · utility
3Cited by
3References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 5, 1991 |
| Grant date | Apr 22, 1997 |
| Priority date | — |
| Expiry date | Sep 5, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions consisting of C1 inhibitor muteins having biological activity similar to C1 inhibitor, but with enhanced resistance to proteolytic cleavage thus rendering such muteins suitable as anti inflammatory agents, preferably for the treatment or prevention of sepsis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.